3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: June 10, 2015
Period of Report: June 8, 2015
Accession Number: 0001250853-15-000044

View Document ↗ View on SEC.gov ↗